Literature DB >> 17551816

HIF-1 mediates the Warburg effect in clear cell renal carcinoma.

Gregg L Semenza1.   

Abstract

Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis in all metazoan species. O(2)-dependent hydroxylation of two proline residues in the HIF-1alpha subunit is necessary for the binding of the von Hippel-Lindau (VHL) protein, which is a component of a ubiquitin protein ligase that ubiquitinates HIF-1alpha, leading to its degradation by the proteasome. In the majority of cases of the clear cell type of renal carcinoma, both VHL genes are inactivated by mutation or epigenetic silencing, leading to dysregulated HIF-1 transcriptional activity. VHL loss-of-function leads, under aerobic conditions, to a HIF-1-dependent reprogramming of glucose and energy metabolism that includes increased glucose uptake, glycolysis, and lactate production accompanied by a reciprocal decrease in respiration. These findings delineate for the first time the molecular mechanisms underlying the Warburg effect in a human cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551816     DOI: 10.1007/s10863-007-9081-2

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  46 in total

1.  Induction of HIF-1alpha in response to hypoxia is instantaneous.

Authors:  U R Jewell; I Kvietikova; A Scheid; C Bauer; R H Wenger; M Gassmann
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

2.  Reversion of transformed glycolysis to normal by inhibition of protein synthesis in rat kidney cells infected with temperature-sensitive mutant of Rous sarcoma virus.

Authors:  R C Carroll; J F Ash; P K Vogt; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway.

Authors:  P J Kallio; W J Wilson; S O'Brien; Y Makino; L Poellinger
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

4.  Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma.

Authors:  Rachel A Craven; Sarah Hanrahan; Nick Totty; Patricia Harnden; Anthea J Stanley; Eamonn R Maher; Adrian L Harris; William S Trimble; Peter J Selby; Rosamonde E Banks
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

5.  Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus.

Authors:  T L Steck; S Kaufman; J P Bader
Journal:  Cancer Res       Date:  1968-08       Impact factor: 12.701

6.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

7.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

8.  Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing.

Authors:  Robert D Guzy; Beatrice Hoyos; Emmanuel Robin; Hong Chen; Liping Liu; Kyle D Mansfield; M Celeste Simon; Ulrich Hammerling; Paul T Schumacker
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

Review 9.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

10.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

View more
  135 in total

Review 1.  Immunologic mechanisms in RCC and allogeneic renal transplant rejection.

Authors:  Jens Bedke; Arnulf Stenzl
Journal:  Nat Rev Urol       Date:  2010-05-11       Impact factor: 14.432

2.  Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury.

Authors:  Marion Hölscher; Monique Silter; Sabine Krull; Melanie von Ahlen; Amke Hesse; Peter Schwartz; Ben Wielockx; Georg Breier; Dörthe M Katschinski; Anke Zieseniss
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

3.  Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation.

Authors:  Jingping Liu; Paul D Hanavan; Katon Kras; Yvette W Ruiz; Erik P Castle; Douglas F Lake; Xianfeng Chen; Daniel O'Brien; Huijun Luo; Keith D Robertson; Haiwei Gu; Thai H Ho
Journal:  J Proteome Res       Date:  2018-11-27       Impact factor: 4.466

4.  Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.

Authors:  Michael P Hay; Kevin O Hicks; Karin Pchalek; Ho H Lee; Adrian Blaser; Frederik B Pruijn; Robert F Anderson; Sujata S Shinde; William R Wilson; William A Denny
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

5.  Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiency.

Authors:  June-Hyung Kim; Hee Young Kim; Young-Kyoung Lee; Young-Sil Yoon; Wei Guang Xu; Joon-Kee Yoon; Sung-E Choi; Young-Gyu Ko; Min-Jung Kim; Su-Jae Lee; Hee-Jung Wang; Gyesoon Yoon
Journal:  Autophagy       Date:  2011-10-01       Impact factor: 16.016

6.  Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.

Authors:  Wei Zhao; Cunjie Chang; Yangyan Cui; Xiaozhi Zhao; Jun Yang; Lan Shen; Ji Zhou; Zhibo Hou; Zhen Zhang; Changxiao Ye; Donald Hasenmayer; Robert Perkins; Xiaojing Huang; Xin Yao; Like Yu; Ruimin Huang; Dianzheng Zhang; Hongqian Guo; Jun Yan
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

7.  A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma.

Authors:  Felipe R Lorenzo; Chunzhang Yang; Mark Ng Tang Fui; Hariprasad Vankayalapati; Zhengping Zhuang; Thanh Huynh; Mathis Grossmann; Karel Pacak; Josef T Prchal
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 8.  Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets.

Authors:  Jamie D Weyandt; Craig B Thompson; Amato J Giaccia; W Kimryn Rathmell
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 9.  Pulmonary arterial hypertension: pathogenesis and clinical management.

Authors:  Thenappan Thenappan; Mark L Ormiston; John J Ryan; Stephen L Archer
Journal:  BMJ       Date:  2018-03-14

10.  Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.

Authors:  Byoung Yong Shim; Ji-Han Jung; Kang-Moon Lee; Hyung-Jin Kim; Sook Hee Hong; Sung Hwan Kim; Der Sheng Sun; Hyeon-Min Cho
Journal:  Int J Colorectal Dis       Date:  2012-07-31       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.